Marathon Petroleum (MPC) says global refined capacity downtime exceeds 9mln bpd
Newsquawk Staff ·
Marathon Petroleum (MPC) says global refined capacity downtime exceeds 9mln bpd.
What it means
Capacity downtime on this scale sits at the intersection of unplanned outages, seasonal maintenance, and capacity permanently shuttered, and in past episodes of this kind the market has cared most about the mix, since planned turnarounds retrace on schedule while unplanned and structural losses tighten product balances durably. The transmission runs through product rather than crude: a heavy outage slate widens crack spreads and supports refining margins even as it weighs on crude intake, which is why comparable periods have tended to leave refiners like MPC bid while crude itself trades two-sided. The distinction worth drawing is between refinery downtime and effective capacity loss, since some offline units return within weeks while others convert to terminals or close outright, a pattern that has persisted since the wave of closures and conversions earlier in the decade. What matters next is the regional composition of the downtime and whether it coincides with peak product demand seasons, as tightness in one basin transmits through arbitrage flows and freight rates to others. As a company remark rather than an independent assessment, the framing serves MPC's margin narrative, so corroboration from agency supply data and observed cracks is the usual check.
- European Movers: L'Oreal (OR FP) +4.8%, Holcim (HOLN SW) +4.5%, Hexagon (HEXAB SS) +3.0%, Eni (ENI IM) +2.3%, Kering (KER FP) -11.0%, Volvo Car (VOLCARB SS) -3.3%
- Newsquawk Daily European Equity Opening News - 23rd October 2026
- Newsquawk Daily European Opening News - 23rd October 2026
- US President Trump posts "Senator Roger Marshall of Kansas has done an incredible job in representing his Great State! Because of him....Bombardier is investing 270 MILLION DOLLARS, creating THOUSANDS of American Jobs in Kansas, Texas, and Indiana"
- US President Trump will deliver remarks in Florida on Friday, Georgia on Saturday and Michigan on Sunday, according to The Whiye House
Related headlines
- Newsquawk Daily Asia-Pac Opening News - 23rd October 20269 hours ago
- US President Trump on Iran, says may do it a little bit further11 hours ago
- US President Trump, on Ukraine’s Starlink (SPCX) access, says it’s a very interesting situation; won’t comment on whether he spoke to Elon Musk; bottom line is Musk put it back11 hours ago
- US TREASURY WRAP: T-NOTE FUTURES (Z6) SETTLE 1 POINT AND 9+ TICKS HIGHER AT 106-1312 hours ago
- US President Trump invokes Section 232 on wind turbine imports12 hours ago
- US President Trump signs EO on housing costs, aiming to cut mortgage insurance premiums12 hours ago
- US President Trump called Musk and asked him to lift Ukraine Starlink (SPCX) restrictions, WSJ reports13 hours ago
- US President Trump says "Iran is doing everything they can to drive up the price of Oil prior to the U.S. Midterm Election". 16 hours ago
- [MARKET ANALYSIS] Asia-Pac stocks are mostly lower following the tech rout and flight-to quality stateside4 hours ago
- Tesla (TSLA) has decided not to proceed with plans to produce Cybertruck for Australia and New Zealand7 hours ago
- OpenAI trims valuation target to USD 1.25tln after previously pitching a higher price, according to FT9 hours ago
- Newmont (NEM) says production growth is expected to begin in 2027 following previously flagged 2026 trough, adds Q3 gold production was broadly flat sequentially as anticipated9 hours ago
- OpenAI is raising up to USD 30bln in funding round at a USD 1.25tln valuation, led by UAE investors, according to CNBC, citing sources; OpenAI is negotiating a commercial deal that would secure more computing capacity from the UAE11 hours ago
- Western Digital (WDC) Q1 2027 (USD): Adj. EPS 4.64 (exp. 4.08), Revenue 4.38bln (exp. 4.14bln)11 hours ago
- Merck & Co (MRK) and Moderna (MRNA) say safety profile of Intismeran plus Keytruda was generally consistent with previously reported studies of combination; significantly reduced the risk of recurrence or death by 42% compared to Keytruda alone13 hours ago